Definitive Contract 75A50121C00077
Award Date
9/30/21
Potential Completion Date
9/29/27
Potential Value
$167M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
BOWLING GREEN, NY 10004, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $149,747,956 definitive cost-no-fee contract awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to the Albert B. Sabin Vaccine Institute, Inc. to advance the development of monovalent vaccines for the prevention of Marburg virus (MARV) and Sudan ebolavirus (SUDV) disease. The contract has an ultimate completion date of September 30, 2026 and was awarded on September 26, 2019. This effort is part of BARDA's...
This is a $177,790.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract is for COORDINATION AND TECHNICAL SUPPORT services under NIAID's PROCESS AND ANALYTICAL SUPPORT FOR DEVELOPMENT OF HIV VACCINES major program. This contract is not designated as a set-aside. IAVI, as the prime contractor, will provide a range of...
This is a delivery order awarded to the International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization, under an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The $26,065,720.00 award is for the manufacture of human influenza challenge material to support IAVI's work on developing vaccines and antibodies to prevent infectious diseases...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to the International AIDS Vaccine Initiative (IAVI), a non-profit organization. The contract has a total ceiling value of $4,687,192.00 and is a delivery order under IAVI's existing indefinite delivery/indefinite quantity (IDIQ) contract with NIAID for preclinical services supporting the development of biopharmaceutical products, including vaccines, for infectious...
This is a $1,327,640.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract is for "COORDINATION AND TECHNICAL SUPPORT" under NIAID's program for "PROCESS AND ANALYTICAL SUPPORT FOR DEVELOPMENT OF HIV VACCINES". IAVI, as the prime contractor, will provide a...
This federal contract award, valued at $1,707,175.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to the International AIDS Vaccine Initiative (IAVI), a global non-profit organization. The contract supports process development for cell culture, upstream and downstream processes in the production of HIV-1 biomolecules, as part of NIAID's broader program for process and analytical support in the...
This is a $26,261,466 cost-plus-fixed-fee contract awarded by the Defense Threat Reduction Agency (DTRA) to the International AIDS Vaccine Initiative (IAVI) to accelerate development of a SARS-CoV-2 vaccine based on the live VSV∆G chimeric virus platform. The contract has no set-aside designation. IAVI is working with several subcontractors, including Trustees of Boston University, Merck Sharp & Dohme LLC, Neogenomics Laboratories, Charles River Laboratories Montreal ULC, and the...
This federal contract award, valued at $3,170,861.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization focused on the development of HIV vaccines. The contract provides for coordination and technical support services to advance the development of HIV vaccines and other infectious disease products.
The contract is a delivery order issued under an Indefinite...
This federal contract award, valued at $508,433.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to the International AIDS Vaccine Initiative (IAVI), a global not-for-profit organization focused on developing HIV vaccines. The contract, which is not a set-aside, supports the analysis of HIV-1 envelope host cell proteins using mass spectrometry methods. IAVI serves as the prime contractor and has partnered with Biosciences Cellcarta Inc. (Caprion) as a...
<p>This is a $81,976,383.00 definitive, cost-plus-fixed-fee contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Public Health Vaccines LLC, a self-certified small disadvantaged business, for the advanced research and development of an RVSV-MARV vaccine. The contract has an ultimate completion date of August 31, 2027 and was awarded on February 1, 2019. The contract does not have a set-aside designation.</p>